Assistant Professor at Pacific Medical College and Hospital, Udaipur, India
Dr. Rohitash Yadav is a highly accomplished researcher with expertise in pharmacology, computational biology, and drug design. Currently serving as an Assistant Professor at Pacific Medical College and Hospital, Udaipur, Dr. Yadav’s research focuses on finding innovative solutions for cancer treatment and infectious diseases. His extensive work on SARS-CoV-2 and multiple myeloma has earned him widespread recognition. Dr. Yadav has authored numerous high-impact scientific articles and has consistently been honored for his contributions to biomedical research.
Profile:
ORCID
Education:
Dr. Yadav holds a PhD from the All India Institute of Medical Sciences (AIIMS), Rishikesh, where he specialized in pharmacology and computational drug design. Prior to this, he earned a Master’s degree in Medical Pharmacology from the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh. His academic journey has equipped him with the necessary skills to lead cutting-edge research projects in both academia and healthcare.
Experience:
Dr. Yadav’s professional journey includes significant research and academic roles. He is currently an Assistant Professor at Pacific Medical College and Hospital, Udaipur. Before that, he served as a Junior Research Fellow at AIIMS Rishikesh, where he was instrumental in leading research initiatives aimed at drug discovery and the development of therapeutic strategies for multiple myeloma and viral diseases. His broad research collaborations span across global institutions, reflecting his leadership in the biomedical field.
Research Interests:
Dr. Yadav’s primary research areas include computational drug design, molecular docking, and in-silico and in-vitro pharmacological studies. He is deeply engaged in the study of potential inhibitors targeting various cancerous pathways, with a strong emphasis on multiple myeloma and COVID-19 therapies. His interdisciplinary approach, combining computational biology with clinical pharmacology, allows for the identification of novel therapeutic compounds and proteins that can be targeted to treat life-threatening diseases.
Awards:
Dr. Yadav has been the recipient of numerous prestigious awards throughout his academic career. His contributions to the biomedical field were recognized by the Best Researcher Award at AIIMS Rishikesh in 2022 and 2023. Additionally, he was awarded the Junior Research Fellowship from AIIMS Rishikesh between 2020-2022. His work on computational biology and drug design has earned him accolades from national and international conferences.
Publications:
Dr. Yadav has an impressive array of publications, including some of the most-cited works in the field. Key publications include:
Yadav R, Mathur I, et al. Dostarlimab: Review on success story and clinical trials. Critical Reviews in Oncology/Hematology (2024). doi:10.1016/j.critrevonc.2024.104374 – Cited by 12 articles.
Gupta SM, Jain NK, Yadav R, et al. Computational investigation of the interaction of novel indene methylene analogues with acetylcholinesterase. Letters in Drug Design & Discovery (2023). doi:10.2174/1570180819666220623144252 – Cited by 18 articles.
Yadav R, Nath UK, et al. Identification and in-vitro analysis of potential proteasome inhibitors for multiple myeloma. Biomedicine & Pharmacotherapy (2023). doi:10.1016/j.biopha.2022.113963 – Cited by 25 articles.
Yadav R, Hasan S, et al. Molecular docking, DFT analysis, and dynamics simulation of natural bioactive compounds targeting ACE2 and TMPRSS2 dual binding sites of spike protein of SARS CoV-2. Journal of Molecular Liquids (2021). doi:10.1016/j.molliq.2021.116942 – Cited by 34 articles.
Yadav R, Celik I, et al. Interactions of the receptor-binding domain of SARS-CoV-2 variants with hACE2: Insights from molecular docking analysis. Biology (2021). doi:10.3390/biology10090880 – Cited by 40 articles.
Yadav R, Kumar JK, et al. Host cell and SARS-CoV-2-associated molecular structures as potential therapeutic targets. Cells (2021). doi:10.3390/cells10092427 – Cited by 28 articles.
Yadav R, Celik I, et al. Investigation of reactive properties, adsorption on fullerene, DFT, molecular dynamics simulation of an anthracene derivative targeting dihydrofolate reductase and human dUTPase. Journal of Biomolecular Structure and Dynamics (2021). doi:10.1080/07391102.2021.1953602 -Cited by 20 articles.
Yadav R, Kumar JK, et al. Insights into COVID-19 vaccine development based on immunogenic structural proteins of SARS-CoV-2. Cells (2021). doi:10.3390/cells10112949 – Cited by 35 articles.
Conclusion:
Dr. Rohitash Yadav’s proven track record in high-impact research, coupled with his leadership in the scientific community and consistent recognition through awards, strongly support his candidacy for the Young Scientist Award. His innovative work in pharmacology, especially in computational drug design, and his proactive engagement with biomedical research make him a well-rounded candidate poised to make significant contributions in the future. However, further emphasis on interdisciplinary collaborations and public outreach could elevate his profile even higher.